trending Market Intelligence /marketintelligence/en/news-insights/trending/vud7daiqnibxljqbnz6sgg2 content esgSubNav
In This List

Arix Bioscience CEO transitioning to chief investment officer

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Arix Bioscience CEO transitioning to chief investment officer

Arix Bioscience PLC said CEO Joe Anderson will become the chief investment officer.

The company added that Anderson will also step down from the board, effective Sept. 4.

Executive Chairman Jonathan Peacock will assume corporate and operating responsibilities and will work with the board to recruit a new CEO.

London-based Arix is an investment company that invests in medical innovation comprising healthcare and the life sciences.